Listen to this story
For five decades, protein folding has been one of the toughest problems in life science. The breakthrough came in 2020 when Google DeepMind successfully tackled this long-standing challenge with AlphaFold. This achievement not only marked a turning point but also unlocked a multitude of possibilities for leveraging AI in drug development and broader healthcare applications.
How AstraZeneca is Using AI Models for Drug Development comes via ChinaTechNews.com.